Oral Health Status in Children With β-Thalassemia Major

May 25, 2026 updated by: Mariam Mohamed Mohamed Diaa eldin Shafie, Cairo University

Effectiveness of a Structured Oral Health Educational Program on Oral Hygiene and Oral Health Related Quality of Life in Children With β-Thalassemia Major: Before and After Interventional Study.

To evaluate the effectiveness of a structured oral health educational program on oral hygiene status and oral health-related quality of life (OHRQoL) among children diagnosed with β-thalassemia.

Study Overview

Detailed Description

Benefits to the patient

  • The clinical examination and OHRQoL assessments provide a well-established foundation to plan the oral-dental treatment for each individual.
  • Improved awareness among β-thalassemia patients and caregivers regarding oral hygiene practices and the importance of regular dental visits may contribute to better oral health outcomes and enhanced overall quality of life.

Benefits to the community

  • Provide valuable epidemiological data on the oral health status and oral health-related quality of life in children with β-thalassemia.
  • Assist dental professionals, healthcare providers, and policymakers in planning targeted preventive strategies and integrating oral health care into the comprehensive management of thalassemia.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children having medical records confirmed of β-thalassemia diagnosis.
  • Age range between 8-10 years old.
  • Have acceptable cooperation

Exclusion Criteria:

  • Children with Cognitive impairment.
  • Participants in another oral health education program or clinical study within the past 6 months will be excluded.
  • Unstable clinical condition as judged by the treating physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: an Immediate Intervention Group
oral health educational program will be given to this group of patients

Oral Health Educational Program

Educational Content (Oral health educational session) including:

  • Interactive lectures with visual aids and video demonstration
  • Correct Tooth brushing technique
  • Frequency & time of brushing
  • How to use mouth rinse and toothpaste
  • How to properly use the dental floss

Teaching Methods

  • Demonstration on dental models
  • Hands-on supervised brushing
  • Use of disclosing agents

Motivational Interviewing

  • Caregiver's guide booklet
  • Dietary counseling
  • Importance of mouth rinse and fluoridated tooth pastes

Materials Used

  • Ultra soft Toothbrushes
  • Alcohol-free mouth rinse
  • Use of fluoridated toothpaste
  • Interdental floss
  • Oral health promotion leaflet
Placebo Comparator: Waitlist Control Group
routine oral hygiene instructions will be given to this group of children
Use toothbrush and toothpaste for oral hygiene Brush twice daily Regular dental checkups Keep toothbrush clean

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral Hygiene
Time Frame: Baseline Measurement and After 1,3 and 6 months

Oral Hygiene Index-Simplified (OHI-S)

Minimum value: 0

Maximum value: 6

Interpretation of scores:

Higher scores indicate worse oral hygiene (greater debris and calculus accumulation).

Lower scores indicate better oral hygiene.

Baseline Measurement and After 1,3 and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral Health Related Quality Of Life (OHRQoL)
Time Frame: Baseline and after 1,3 and 6 months

Measured using Child Perception Questionnaire (children aged 8-10 years) Child Perceptions Questionnaire for children aged 8-10 years (CPQ8-10)

Minimum value: 0

Maximum value: 100

Interpretation of scores:

Higher scores indicate a worse oral health-related quality of life (greater negative impact on the child's well-being).

Lower scores indicate a better oral health-related quality of life.

Baseline and after 1,3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Abbas, F., Tabesh, A., Yavari, A., Makaremi, R., Bizhani, O. and Mahmood, M. (2023) 'Evaluation and relation of oral health-related quality of life and oral health status in Thalassemia Major patients, a cross-sectional study', BMC Oral Health, 23(493), pp. 1-9. Available at: doi.org. Al-Blaihed, D., El-Housseiny, A.A., Farsi, N.J. and Farsi, N.M. (2020) 'Validity and reliability of the Arabic version of the child perceptions questionnaire for 8-10-year-old children', Quality of Life Research, 29(11), pp. 3119-3125. Available at: https://doi.org/10.1007/s11136-020-02545-y. Amirabadi, F., Saravani, S., Miri-Aliabad, G., Khorashadi-Zadeh, M. (2019). 'The Association between Dental Health Status and Oral Health-Related Quality of Life of Children Diagnosed with β-Thalassemia Major in Zahedan City, Iran', Journal of Pediatric Perspectives, 7(2), pp. 8985-8991. doi: 10.22038/ijp.2018.34517.3034 Barriault, S., Deneault, A.-A., Kempe, S., Madigan, S., Lovegrove, A., Dimitropoulos, G., Pillai Riddell, R. and Racine, N. (2019) 'A randomized waitlist control trial of the Make the Connection® online program for caregivers of infants and young children: Study protocol', BMC Pediatrics, 19, p. 176. https://doi.org/10.1186/s12887-019-1567-2 Desveaux, L., Agarwal, P., Shaw, J., Hensel, J.M., Mukerji, G., Onabajo, N., Marani, H., Jamieson, T., Bhattacharyya, O., Martin, D., Mamdani, M., Jeffs, L., Wodchis, W.P., Ivers, N.M. and Bhatia, R.S. (2018) 'A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol', BMC Medical Informatics and Decision Making, 18, Article 49. https://doi.org/10.1186/s12911-018-0613-5 El-Kamah, G., Adam, S., Magdy, P., Michel, M. and Afifi, H. (2014) 'Quality of life outcomes among Egyptian children with beta-thalassemia', Blood, 124(21), p. 4864. Fadel, H.T., Zolaly, M.A., Alharbi, M.O., Qarah, L.A., Alrehili, M.S., Alamri, A.D. and Tarawah, A.M. (2

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

May 18, 2026

First Submitted That Met QC Criteria

May 25, 2026

First Posted (Actual)

May 29, 2026

Study Record Updates

Last Update Posted (Actual)

May 29, 2026

Last Update Submitted That Met QC Criteria

May 25, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • OHRQOL in β-TM children

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on B Thalassemia Major

Clinical Trials on oral health educational program for Immediate Intervention Group

Subscribe